| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/LABINVEST.2012.57 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/labinvest.2012.57 |
| P698 | PubMed publication ID | 22469699 |
| P5875 | ResearchGate publication ID | 223982329 |
| P50 | author | Gunilla Westergren-Thorsson | Q66125046 |
| P2093 | author name string | Dick Heinegård | |
| Tore Saxne | |||
| Roger Hesselstrand | |||
| Kristina Rydell-Törmänen | |||
| Juha Risteli | |||
| Kristofer Andréasson | |||
| P2860 | cites work | Cellular and molecular mechanisms of fibrosis | Q24648892 |
| Direct evidence of secondary necrosis of neutrophils during intense lung inflammation | Q33235178 | ||
| Animal models of acute lung injury | Q34795312 | ||
| Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin | Q35085416 | ||
| Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction | Q35543612 | ||
| Bleomycins: towards better therapeutics | Q36026763 | ||
| The respiratory system in connective tissue disorders | Q36117547 | ||
| Idiopathic interstitial pneumonias: usual interstitial pneumonia versus nonspecific interstitial pneumonia | Q36403147 | ||
| The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | Q36970923 | ||
| Murine models of pulmonary fibrosis. | Q36997546 | ||
| Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice. | Q37343785 | ||
| Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease. | Q37738691 | ||
| Fibroblasts and myofibroblasts: what are we talking about? | Q37836316 | ||
| ??? | Q28215495 | ||
| Pulmonary toxicity of bleomycin | Q39422182 | ||
| Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention | Q42952062 | ||
| Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice | Q45285621 | ||
| Allergen exposure of mouse airways evokes remodeling of both bronchi and large pulmonary vessels | Q47921757 | ||
| The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices | Q47962630 | ||
| Scleroderma | Q54165664 | ||
| Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice | Q69101714 | ||
| Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis | Q72706443 | ||
| Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study | Q73977486 | ||
| Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma | Q77319152 | ||
| Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung | Q80332839 | ||
| Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms | Q84762346 | ||
| P433 | issue | 6 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 917-925 | |
| P577 | publication date | 2012-04-02 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis. | |
| P478 | volume | 92 |
| Q37176705 | 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo |
| Q37664164 | A mouse model of chronic idiopathic pulmonary fibrosis |
| Q42293031 | Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma |
| Q41241209 | Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation |
| Q38739370 | Advanced Role of Neutrophils in Common Respiratory Diseases |
| Q38811356 | An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis. |
| Q90132747 | Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance |
| Q37297925 | Animal models of fibrotic lung disease |
| Q61800612 | Attenuation of lipopolysaccharide-induced lung inflammation by ascorbic acid in rats: Histopathological and ultrastructural study |
| Q36141637 | Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway |
| Q37596505 | Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury |
| Q52717760 | Estrogen receptor beta signaling inhibits PDGF induced human airway smooth muscle proliferation. |
| Q53061036 | Expression and mechanism of BRP-39 in bleomycin-induced pulmonary fibrosis in rat. |
| Q34442676 | Obesity induced by neonatal overfeeding worsens airway hyperresponsiveness and inflammation |
| Q38243843 | Origin of myofibroblasts and cellular events triggering fibrosis |
| Q50912679 | Procollagen I-expressing renin cell precursors. |
| Q27321863 | Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection |
| Q48130563 | Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - a potential pathway affecting proliferation |
| Q36256033 | Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis |
| Q46670121 | ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling |
| Q37644229 | Structural environment built by AKAP12+ colon mesenchymal cells drives M2 macrophages during inflammation recovery |
| Q91786589 | The Applicability of Mouse Models to the Study of Human Disease |
| Q38290539 | The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis |
| Q39072592 | The progress and challenges for dermal regeneration in tissue engineering |
| Q28250984 | Versican in inflammation and tissue remodeling: the impact on lung disorders |
Search more.